Jazz Pharmaceuticals plc (JAZZ) › Cash & EquivalentsJazz Pharmaceuticals plc (JAZZ) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2008-12-31: $24.90M2009-12-31: $15.60M2010-12-31: $44.79M2011-12-31: $82.08M2012-12-31: $387.20M2013-12-31: $636.50M2014-12-31: $684.04M2015-12-31: $988.78M2016-12-31: $365.96M2017-12-31: $386.04M2018-12-31: $309.62M2019-12-31: $637.34M2020-12-31: $1.06B2021-12-31: $591.45M2022-12-31: $881.48M2023-12-31: $1.51B2024-12-31: $2.41B2025-12-31: $1.39B$1.39B2008-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$1.39B-42.3%2026-02-24Balance as of period end2024-12-31$2.41B+60.2%2026-02-24Balance as of period end2023-12-31$1.51B+70.9%2025-02-26Balance as of period end2022-12-31$881.48M+49.0%2024-02-28Balance as of period end2021-12-31$591.45M-44.1%2023-03-01Balance as of period end2020-12-31$1.06B+66.0%2022-03-01Balance as of period end2019-12-31$637.34M+105.8%2021-02-23Balance as of period end2018-12-31$309.62M-19.8%2020-02-25Balance as of period end2017-12-31$386.04M+5.5%2019-02-26Balance as of period end2016-12-31$365.96M-63.0%2019-02-26Balance as of period end2015-12-31$988.78M+44.6%2019-02-26Balance as of period end2014-12-31$684.04M+7.5%2018-02-27Balance as of period end2013-12-31$636.50M+64.4%2017-02-28Balance as of period end2012-12-31$387.20M+371.8%2016-02-23Balance as of period end2011-12-31$82.08M+83.2%2015-02-24Balance as of period end2010-12-31$44.79M+187.2%2014-02-25Balance as of period end2009-12-31$15.60M-37.4%2013-02-26Balance as of period end2008-12-31$24.90M—2012-02-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)